Non-histone lactylation in cancer: current advances and clinical implications - Takeaways - MDSpire

Non-histone lactylation in cancer: current advances and clinical implications

  • By

  • Yang, Robert Le

  • Liang, Yiran

  • May 18, 2026

  • 0 min

Share

  • 1

    Lactylation is a novel post-translational modification that involves the attachment of lactate to lysine residues.

  • 2

    Non-histone lactylation significantly influences tumor proliferation, metastasis, and therapy resistance.

  • 3

    Key enzymes involved in lactylation include lysine acetyltransferases, deacetylases, and alanyl-tRNA synthetases.

  • 4

    Therapeutic strategies targeting lactate-driven pathways include small-molecule inhibitors and peptides.

  • 5

    Non-histone lactylation represents a promising area for cancer research, linking metabolism and tumor biology.

Original Source(s)

Non-histone lactylation in cancer: current advances and clinical implications

  • by Yang, Robert Le, Liang, Yiran

  • May 18, 2026

Related Content

Prospective phase II study of frontline Helicobacter pylori eradication therapy for early-stage extragastric mucosa-associated lymphoid tissue lymphoma

The role of NAD+ metabolic reprogramming in colorectal cancer chemoresistance: mechanistic insights, clinical translation challenges and opportunities

Gastric-type endocervical adenocarcinoma with Peutz-Jeghers syndrome: a case report and literature review